Financials • Specialty Insurers
$47.57 ▲ +1.27
(+2.74%)
MKT CAP: $1.69B • VOL: 210.9K
52W L $34 52W H $80
ROARABLE / RQD
C+ • 69/100
PIOTROSKI
5 / 9
GSHD // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $365.3M | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $74.4M | $61.1M | $33.0M |
| Operating Margin % | 20.4% | — | — |
| Net Income (GAAP) | $27.8M | $30.4M | $14.1M |
| EBITDA (Normalized) | $79.0M | $61.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $91.8M | $71.5M | $50.8M |
| Capital Expenditures (CapEx) | $5.7M | $979.0K | — |
| Free Cash Flow (FCF) | $86.1M | $70.6M | $50.8M |
| FCF Margin % | 23.6% | — | — |
| Return on Invested Capital (ROIC %) | 36.9% | 67.2% | — |
| Cash & Short-Term Equivalents | $34.4M | $54.3M | — |
| Total Debt (Short + Long Term) | $289.5M | $82.3M | — |
| Total Stockholders' Equity | -$95.5M | $43.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR GSHD.